U.S. flag

An official website of the United States government

Display Settings:

Format

Send to:

Choose Destination
Luspatercept (Reblozyl): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with very low- to intermediate-risk myelodysplastic syndromes (MDS)-associated anemia who have ring sideroblasts and require red blood cell (RBC) transfusions [Internet].

Luspatercept (Reblozyl): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with very low- to intermediate-risk myelodysplastic syndromes (MDS)-associated anemia who have ring sideroblasts and require red blood cell (RBC) transfusions [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2021 Dec.

Table of contents


Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...